Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

RMJ. 2007; 32(1): 8-10


Low dose of remifentanil in facilitation of Insertion of Laryngeal mask airway

H.Hoseinzade, M.Eidy, M. Ansari, D. Aghamohammadi, N.Ghorbabian A.Mahmoudpour.




Abstract

Objective: To evaluate the effect of injection of remifentanil with propofol in decreasing the
undesirable anesthetic airway responses such as coughing and gagging.
Methods: We performed a randomized double-blind study from October 2003 to May 2004, in
Emam Hospital in Tabriz, Iran, to compare the condition during insertion of LMA in 90 patients
with ASA classes I and II, in 3 groups. Group R1 received 0.25 μg/kg remifentaniel and 2.5
mg/kg propofol, Group R2 0.5 μg/kg remifentanil and 2.5 mg/kg propofol, and Group P normal
saline and 2.5 mg/kg propofol. Hemodynamic changes, apneic time, condition of insertion and
airway patency were compared in these groups.
Results: Remifentanil significantly improved the condition of insertion in-group R1: 80.33% and
group R2: 90.6% in comparison with group P 40%. Hemodynamic changes in-group R1 was less
than R2. Patients in-group R1 were apneic for a mean time of 1.75 ± 0.9 min as compared with
2.35± 1.3 min in-group R2.
Conclusion: Administration of 0.25-μg/kg remifentanil with 2.5 mg/kg propofol caused less
hemodynamic changes and provided excellent condition for insertion of the LMA.(Rawal Med J
2007;32:8-10)

Key words: Airway, remifentanil, propofol, intubation.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.